Clinical Trial Update: The Cost-effectiveness of Artificial Intelligence Acute Kidney Injury Prediction Auxiliary Software (Acura AKI) [NA]

View source ↗

Summary

Clinical trial update evaluating the cost-effectiveness of Acura AKI, an AI-based acute kidney injury prediction software, in intensive care settings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Snippet

Sponsor: Huede Healthtech Co., Ltd. | Conditions: Acute Kidney Injury, Intensive Care | NA | Status: RECRUITING